Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1972 1
1973 1
1975 1
1978 1
1981 1
1986 1
1988 2
1989 1
1992 2
1993 4
1994 3
1995 2
1996 3
1997 1
1998 1
1999 1
2002 1
2003 2
2004 5
2007 1
2008 2
2009 7
2010 1
2011 3
2012 4
2013 3
2014 6
2015 3
2016 4
2017 3
2018 2
2019 9
2020 10
2021 11
2022 8
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, Díaz R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG; SCORED Investigators. Bhatt DL, et al. N Engl J Med. 2021 Jan 14;384(2):129-139. doi: 10.1056/NEJMoa2030186. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200891 Clinical Trial.
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators; Freij A, Thorsén M. Wallentin L, et al. N Engl J Med. 2009 Sep 10;361(11):1045-57. doi: 10.1056/NEJMoa0904327. Epub 2009 Aug 30. N Engl J Med. 2009. PMID: 19717846 Free article. Clinical Trial.
Neonatal Simulation Program: A 5 Years Educational Journey From Qatar.
Bayoumi MAA, Elmalik EE, Ali H, D'Souza S, Furigay J, Romo A, Shyam S, Singh R, Koobar O, Al Shouli J, van Rens M, Abounahia FF, Gad A, Elbaba M, Lutfi S. Bayoumi MAA, et al. Front Pediatr. 2022 Mar 21;10:843147. doi: 10.3389/fped.2022.843147. eCollection 2022. Front Pediatr. 2022. PMID: 35386259 Free PMC article.
Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys.
Ominsky MS, Boyd SK, Varela A, Jolette J, Felx M, Doyle N, Mellal N, Smith SY, Locher K, Buntich S, Pyrah I, Boyce RW. Ominsky MS, et al. J Bone Miner Res. 2017 Apr;32(4):788-801. doi: 10.1002/jbmr.3036. Epub 2016 Dec 13. J Bone Miner Res. 2017. PMID: 27865001 Free article.
Romosozumab (Romo), a humanized sclerostin antibody, is a bone-forming agent under development for treatment of osteoporosis. ...
Romosozumab (Romo), a humanized sclerostin antibody, is a bone-forming agent under development for treatment of osteoporosis. …
A novel cacalolide from Psacalium decompositum.
Reyes-Chilpa R, Jiménez-Estrada M, Godínez MV, Hernández-Ortega S, Campos M, Béjar E. Reyes-Chilpa R, et al. Nat Prod Lett. 2002 Aug;16(4):239-42. doi: 10.1080/10575630290020532. Nat Prod Lett. 2002. PMID: 12168758
A new cacalolide sesquiterpenoid, named as Romo-A, was isolated from the roots of Psacalium decompositum, Asteraceae, a Mexican medicinal shrub with antidiabetic properties. ...
A new cacalolide sesquiterpenoid, named as Romo-A, was isolated from the roots of Psacalium decompositum, Asteraceae, a Mexica …
115 results